Elevated prostaglandin E2 post-bone marrow transplant mediates interleukin-1β-related lung injury

Mucosal Immunol. 2018 Mar;11(2):319-332. doi: 10.1038/mi.2017.51. Epub 2017 Jun 7.

Abstract

Hematopoietic stem cell transplant (HSCT) treats or cures a variety of hematological and inherited disorders. Unfortunately, patients who undergo HSCT are susceptible to infections by a wide array of opportunistic pathogens. Pseudomonas aeruginosa bacteria can have life-threatening effects in HSCT patients by causing lung pathology that has been linked to high levels of the potent pro-inflammatory cytokine, interleukin-1β (IL-1β). Using a murine bone marrow transplant (BMT) model, we show that overexpression of prostaglandin E2 (PGE2) post-BMT signals via EP2 or EP4 to induce cyclic adenosine monophosphate (cAMP), which activates protein kinase A or the exchange protein activated by cAMP (Epac) to induce cAMP response element binding-dependent transcription of IL-1β leading to exacerbated lung injury in BMT mice. Induction of IL-1β by PGE2 is time and dose dependent. Interestingly, IL-1β processing post-P. aeruginosa infection occurs via the enzymatic activity of either caspase-1 or caspase-8. Furthermore, PGE2 can limit autophagy-mediated killing of P. aeruginosa in alveolar macrophages, yet autophagy does not have a role in PGE2-mediated upregulation of IL-1β. Reducing PGE2 levels with indomethacin improved bacterial clearance and reduced IL-1β-mediated acute lung injury in P. aeruginosa-infected BMT mice.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Dinoprostone / metabolism*
  • Disease Models, Animal
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Indomethacin / therapeutic use
  • Interleukin-1beta / metabolism
  • Lung Injury / drug therapy
  • Lung Injury / etiology
  • Lung Injury / immunology*
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / immunology*
  • Macrophages, Alveolar / microbiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Postoperative Complications / drug therapy
  • Postoperative Complications / immunology*
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / etiology
  • Pseudomonas Infections / immunology*
  • Pseudomonas aeruginosa / physiology*
  • Receptors, Prostaglandin E, EP2 Subtype / metabolism
  • Signal Transduction
  • Up-Regulation

Substances

  • Interleukin-1beta
  • Receptors, Prostaglandin E, EP2 Subtype
  • Cyclic AMP
  • Dinoprostone
  • Indomethacin